Search Results 1591-1600 of 20016 for Hepatitis b

1. A Study Of ATR-101 For The Treatment Of Cushing’s Syndrome - Mayo Clinic

   HIV, hepatitis B, or hepatitis C positivity at screening; Any malignancy within the previous 10 years, other than curatively resected basal or squamous cell ...

2. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients - Mayo Clinic

   Has known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [qualitative] is detected). Has received a live vaccine within 30 days ...

3. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   ... Hepatitis B or Hepatitis C; Chemotherapy, radiotherapy, biologics, and/or other treatment with immunotherapy not completed four (4) weeks prior to first dose ...

4. A Study to Compare Nivolumab or Brentuximab Vedotin Plus Combination Chemotherapy to Treat Patients with Newly-diagnosed Stage III-IV Classic Hodgkin Lymphoma - Mayo Clinic

   Patients must not have known active hepatitis B (HBV) or hepatitis C virus (HCV) at date of registration. Patients with previously treated HBV or HCV that ...

5. Deucravacitinib (oral route) - Side effects & dosage - Mayo Clinic

   Liver disease (eg, hepatitis B or C) or; Tuberculosis, history of—Use with caution. May make these conditions worse. Infection, active or; Liver disease ...

6. A Study to Evaluate the Safety and Effectiveness of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease - Mayo Clinic

   Hepatitis B. Subject has positive test results for Human Immunodeficiency Virus (HIV) or known to be HIV-positive. Phase 1b subject cannot be a current ...

7. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

   Active, uncontrolled infection, including hepatitis B, hepatitis C. Concurrent anti-cancer therapy, including chemotherapy agents, targeted agents, or ...

8. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... hepatitis carrier [for example, hepatitis B surface antigen (HBsAg) positive]). Screening is not required for enrollment. Have received any recent (within ...

9. A Phase 3 Study To Evaluate The Effect Of Resmetirom On Clinical Outcomes In Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) - Mayo Clinic

   ... Hepatitis B positive, Hepatitis C, history or evidence of current active autoimmune hepatitis, history or evidence of Wilson's disease, history or ...

10. Thalassemia - Diagnosis and treatment - Mayo Clinic

    It's a B vitamin that helps build red blood cells. ... You'll also need an annual flu shot, as well as vaccines to prevent meningitis, pneumonia and hepatitis B.